Last reviewed · How we verify
NCT06682065: TECC
Telemedicine Contraceptive Counselling (TECC) Versus Standard Care
NA trial testing Telemedicine for contraceptive counseling (TECC) in Contraceptive Usage in 510 participants. Currently enrolling.
15 February 2025
Quick facts
| Lead sponsor | Karolinska Institutet |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 510 |
| Start date | 5 May 2024 |
| Primary completion | 15 February 2025 |
| Estimated completion | 15 February 2026 |
| Sites | 2 locations across South Africa |
Drugs / interventions tested
- Telemedicine for contraceptive counseling (TECC)
- Standard Care — full drug profile →
Conditions studied
- Contraceptive Usage — all drugs for Contraceptive Usage →
- Telemedicine — all drugs for Telemedicine →
Sponsor
Karolinska Institutet
Who can join
18 and older, female only, with Contraceptive Usage or Telemedicine. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Overall purpose of the PILOT and RCT: This research project aims to increase access and uptake of contraception after abortion through the systematic development and testing of a new telemedicine service for contraceptive counselling (TECC). The investigators will perform a pilot study in South Africa, and multicenter randomized controlled trial in South Africa and Kenya with the following specific aims:
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06682065
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Contraceptive Usage
Currently open trials in the same condition.
- NCT07039591 — Assess Performance Attributes and Acceptability of Non-medicated Intravaginal Rings Among Sexually Active Women in Atlan · EARLY_PHASE1 · recruiting
- NCT05674513 — Disparities in Emergency Contraceptive Metabolism Dictate Efficacy · Phase 4 · recruiting
- NCT04558229 — RCT Evaluating Standardized Counseling on Early Discontinuation for Irregular Bleeding in Nexplanon Users · Phase 4 · active not recruiting
- NCT03984695 — Sexual Health Empowerment for Women's Health · NA · active not recruiting
Other Karolinska Institutet trials
Trials by the same sponsor.
- NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
- NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
- NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
- NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
- NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06682065 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
- Last refreshed: 12 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06682065.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing